Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/171465
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorMuñoz Santiago, Silvia-
dc.contributor.authorMéndez, Lucía-
dc.contributor.authorDasilva, Gabriel-
dc.contributor.authorTorres, Josep Lluís-
dc.contributor.authorRamos-Romero, Sara-
dc.contributor.authorRomeu, Marta-
dc.contributor.authorNogués, M. R.-
dc.contributor.authorMedina, Isabel-
dc.date.accessioned2018-10-24T08:16:39Z-
dc.date.available2018-10-24T08:16:39Z-
dc.date.issued2018-09-26-
dc.identifier.citationMarine Drugs 16(10): 353 (2018)-
dc.identifier.urihttp://hdl.handle.net/10261/171465-
dc.description.abstractThe present study addressed the ability of long-chain ω-3 polyunsaturated fatty acids (ω-3 PUFA), i.e., eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), to ameliorate liver protein damage derived from oxidative stress and induced by consumption of high-caloric diets, typical of Westernized countries. The experimental design included an animal model of Sprague-Dawley rats fed high-fat high-sucrose (HFHS) diet supplemented with ω-3 EPA and DHA for a complete hepatic proteome analysis to map carbonylated proteins involved in specific metabolic pathways. Results showed that the intake of marine ω-3 PUFA through diet significantly decreased liver protein carbonylation caused by long-term HFHS consumption and increased antioxidant system. Fish oil modulated the carbonylation level of more than twenty liver proteins involved in critical metabolic pathways, including lipid metabolism (e.g., albumin), carbohydrate metabolism (e.g., pyruvate carboxylase), detoxification process (e.g., aldehyde dehydrogenase 2), urea cycle (e.g., carbamoyl-phosphate synthase), cytoskeleton dynamics (e.g., actin), or response to oxidative stress (e.g., catalase) among others, which might be under the control of diet marine ω-3 PUFA. In parallel, fish oil significantly changed the liver fatty acid profile given by the HFHS diet, resulting in a more anti-inflammatory phenotype. In conclusion, the present study highlights the significance of marine ω-3 PUFA intake for the health of rats fed a Westernized diet by describing several key metabolic pathways which are protected in liver.-
dc.description.sponsorshipThis research was founded by the Spanish Ministry of Science and Innovation (grant number AGL2013-49079-C2-1-R) and The Consejo Superior de Investigaciones Científicas (CSIC). Both are gratefully acknowledged for the doctoral fellowship to Silvia Muñoz Xunta de Galicia is also thankfully recognized for the financial support of the postdoctoral contract to Lucía Méndez The authors thank Lorena Barros, Salomé Lois and Maria Jesus González for their technical assistance.-
dc.publisherMultidisciplinary Digital Publishing Institute-
dc.relationinfo:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/AGL2013-49079-C2-1-R-
dc.relation.isversionofPublisher's version-
dc.rightsopenAccess-
dc.subjectOxidative stress-
dc.subjectHigh-fat high-sucrose diet-
dc.subjectLiver protein damage-
dc.subjectMarine omega-3 fatty acids-
dc.subjectCarbonylation-
dc.subjectFish oils-
dc.subjectSprague-dawley rat-
dc.titleTargeting hepatic protein carbonylation and oxidative stress occurring on diet-induced metabolic diseases through the supplementation with fish oils.-
dc.typeartículo-
dc.identifier.doi10.3390/md16100353-
dc.description.peerreviewedPeer reviewed-
dc.relation.publisherversionhttps://doi.org/10.3390/md16100353-
dc.identifier.e-issn1660-3397-
dc.date.updated2018-10-24T08:16:40Z-
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0/-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderConsejo Superior de Investigaciones Científicas (España)-
dc.contributor.funderXunta de Galicia-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003339es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100010801es_ES
dc.identifier.pmid30261666-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.openairetypeartículo-
item.fulltextWith Fulltext-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Aparece en las colecciones: (IIM) Artículos
(IQAC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
marinedrugs-16-00353.pdf3,22 MBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

11
checked on 10-may-2024

SCOPUSTM   
Citations

20
checked on 22-may-2024

WEB OF SCIENCETM
Citations

20
checked on 28-feb-2024

Page view(s)

267
checked on 22-may-2024

Download(s)

456
checked on 22-may-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons